Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.

@article{Smolyakov2003NosocomialMR,
  title={Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.},
  author={Rozalia Smolyakov and Abraham Borer and Klaris Riesenberg and Francisc Schlaeffer and Michael Alkan and Avi Porath and Doron Rimar and Yaniv Y Almog and Jacob Gilad},
  journal={The Journal of hospital infection},
  year={2003},
  volume={54 1},
  pages={32-8}
}
The emergence of multidrug-resistant (MDR) Acinetobacter baumannii poses a therapeutic problem. The aim of this study was to assess the risk factors for nosocomial MDR-A. baumannii bloodstream infection (BSI) and the efficacy of ampicillin-sulbactam (A/S) in its treatment. Of 94 nosocomial A. baumannii BSI during the year 2000, 54% involved MDR strains, 81% of which were genetically related. Various risk factors for MDR-A. baumannii were found, of which intensive-care unit admission and prior… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.

Diagnostic microbiology and infectious disease • 2007
View 4 Excerpts
Highly Influenced

Risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial Acinetobacter nosocomialis bacteremia.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi • 2016
View 1 Excerpt

Similar Papers

Loading similar papers…